Caplin Point Laboratories Ltd share price
Caplin Point Laboratories Ltd (CAPLIPOINT) is a stock listed on India's exchanges (NSE & BSE). On Traddx you can view its live price, interactive candlestick charts with 20/50/200-day moving averages and golden/death-cross detection, quarterly results, analyst price targets, peer comparison, and the smart-money signal — which star investors hold it and who is buying it on today's bulk/block deals tape.
Caplin Point Laboratories Limited value chain — customers, suppliers & competitors
Caplin Point Laboratories manufactures and sells pharmaceutical finished formulations and APIs, focusing heavily on emerging markets like Latin America and Africa while expanding into regulated markets like the US through its subsidiary Caplin Steriles.
🛒 Customers — who buys from Caplin Point Laboratories Limited
- Latin American Distributors & Wholesalers — Finished pharmaceutical formulations
- Global Institutional Buyers & Partners — Injectables and sterile products
⛓️ Suppliers — raw materials & inputs
- Active Pharmaceutical Ingredients (APIs) and Chemical Vendors — Raw chemical compounds and active ingredients
- Packaging Material Suppliers — Vials, ampoules, foils, and cartons
⚔️ Competitors — other sellers
- Lupin Limited — Competes in global generic formulations and regulated markets on a much larger scale.
- SMS Pharmaceuticals Limited — Competes primarily in the API manufacturing segment.
- RPG Life Sciences Limited — Competes in domestic and international branded and generic formulations.
🔀 Other suppliers to its customers
- Dr. Reddy's Laboratories — Supplies generic formulations and injectables globally.
- Sun Pharmaceutical Industries — Major alternative supplier of finished pharmaceutical products across similar international geographies.
🤝 Peers that share its suppliers
- Aurobindo Pharma — Shares similar chemical and packaging raw material supply chains for generic drug manufacturing.
- Divi's Laboratories — Shares common API and raw chemical material sourcing ecosystems in the Indian pharmaceutical industry.
This value-chain map is AI-researched from public sources; company links and any figures are estimates, not official company disclosures. Not investment advice.